Discontinuation of Biosimilar Infliximab Associated With Subjective Complaints
Transitioning from an originator agent to its biosimilar has the potential to reduce healthcare costs without compromising outcomes.
Spondyloarthritis 2017
Etanercept for Spondyloarthritis: Impact on Disease Progression
The use of tumor necrosis factor inhibitors to modify structural changes in axial spondyloarthritis may prevent progression to spinal disease.
Secukinumab Long-Term Reduction of Radiographic Progression in Ankylosing Spondylitis
For patients with ankylosing spondylitis, secukinumab may reduce radiographic progression and remain effective in the long-term.
Draft Psoriatic Arthritis Guideline Presented at ACR 2017
The guideline includes recommendations for treating adult patients with active psoriatic arthritis.
TNF Inhibitors Decrease Extraarticular Manifestations in Ankylosing Spondylitis
Treatment with TNF inhibitors has led to improvement in physical function and quality of life in patients with ankylosing spondylitis.
Tofacitinib Improves Patient-Reported Outcomes for Active Psoriatic Arthritis
Results from phase 3 trials OPAL Broaden (NCT01877668) and OPAL Beyond (NCT01882439) presented at the American College of Rheumatology 2017 in San Diego, California.
Local Inflammation Predicts Structural Damage in Axial Spondyloarthritis
Researchers recruited patients with recent onset axial spondyloarthritis and conducted MRI of the spine or MRI of the sacroiliac joints at baseline, 2 years, and 5 years.
Higher Prevalence of Depression, ADHD Observed Among Women With Psoriatic Arthritis
Researchers observed a higher prevalence of psychiatric disorders among female patients with psoriatic arthritis.
Pregnancy Outcomes in SLE vs Other Connective Tissue, Inflammatory Rheumatic Conditions
Real-world data indicate that although most patients with systemic lupus erythematosus or connective tissue diseases have successful pregnancies, more adverse pregnancy outcomes occur.
Long-Term Safety of Adalimumab in Immune-Related Diseases Analyzed
Investigators sought to determine the long-term safety of adalimumab use in patients with arthritis and other immune-related diseases.
Next post in ACR 2017 Coverage
